Document:

Exhibit
10.10

 

THE
OFFER AND SALE OF THIS SECOND AMENDED AND RESTATED PROMISSORY NOTE (THIS “NOTE”) HAS NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY
NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL
REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.  

 

SECOND AMENDED AND
RESTATED PROMISSORY NOTE

 

	Principal Amount:  Up to $300,000	
    Dated as of December 13, 2021

    Shaker Heights, Ohio

 

Gardiner
Healthcare Acquisitions Corp., a Delaware corporation and blank check company (the “Maker”), promises to pay to
the order of Gardiner Healthcare Holdings, LLC, a Delaware limited liability company or its registered assigns or successors in interest
(together, the “Payee”), the principal sum of up to Three Hundred Thousand Dollars ($300,000) (the “Maximum
Amount”) in lawful money of the United States of America, on the terms and conditions described below. All payments on this
Note shall be made by check or wire transfer of immediately available funds, or as otherwise determined by Maker, to such account as Payee
may from time to time designate by Notice (as defined in Section 9) to Maker in accordance with the provisions of this Note.

 

This
Note amends, restates, replaces and supersedes that certain Amended and Restated Promissory Note dated July 30 (the “Existing
Note”), in the original principal amount of $300,000 executed by Maker in favor of Payee. From and after the execution and delivery
of this Note, (i) the indebtedness heretofore evidenced by the Existing Note shall instead be evidenced by this Note, and (ii) the Existing
Note shall thereupon be deemed cancelled.

 

1.            
 Principal. The principal balance of this Note shall be payable by Maker on the earlier of: (i) March 31, 2022 (the “Maturity
Date”) or (ii) the date on which Maker consummates an initial public offering of its securities (the “IPO”).
The principal balance may be prepaid at any time. Under no circumstances shall any individual, including but not limited to any officer,
director, employee or shareholder of Maker, be obligated personally for any obligations or liabilities of Maker hereunder.

 

2.            
Interest. No interest shall accrue on the unpaid principal balance of this Note.

 

3.             Drawdown
Requests. Maker and Payee agree that Maker may request from the Payee or its affiliates up to the Maximum Amount for costs
reasonably related to Maker’s initial public offering of its securities (which amount shall include any amounts funded to date
by the Payee or its affiliates). The principal of this Note may be drawn down from time to time prior to the earlier of: (i)
December 31, 2021; or (ii) the date on which Maker consummates an initial public offering of its securities, upon written request
from Maker to Payee (each, a “Drawdown Request”). Each Drawdown Request must state the amount to be drawn down,
and must not be an amount less than Ten Thousand Dollars ($10,000), unless agreed upon by Maker and Payee. Payee shall fund each
Drawdown Request no later than five business days after receipt of a Drawdown Request; provided, however, that the maximum
amount of drawdowns collectively under this Note shall not exceed the Maximum Amount. Once an amount is drawn down under this Note,
such amount shall not be available for future Drawdown Requests, even if such amount is prepaid. No fees, payments or other amounts
shall be due to Payee in connection with, or as a result of, any Drawdown Request by Maker. Notwithstanding the foregoing, all
payments shall be applied, first, to payment in full of any costs incurred in the collection of any sum due under this Note,
including (without limitation) reasonable attorneys’ fees, and second, to the reduction of the unpaid principal balance
of this Note.

 

     

     

    

 

4.            
Application of Payments. All payments shall be applied, first, to payment in full of any costs incurred in the collection
of any sum due under this Note, including (without limitation) reasonable attorney’s fees, second, to the payment in full
of any late charges, and third, to the reduction of the unpaid principal balance of this Note.

 

5.            
Events of Default. The following events shall constitute an event of default (“Event of Default”):

 

5.1              
Failure to Make Required Payments. The failure by Maker to pay the principal amount due pursuant to this Note within
five business days of the Maturity Date.

 

5.2              
Voluntary Bankruptcy, Etc. The: (a) commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency,
reorganization, rehabilitation or other similar law; (b) consent by Maker to the appointment of or taking possession by a receiver, liquidator,
assignee, trustee, custodian, sequestrator (or other similar official) of Maker for any substantial part of its property, (c) making by
Maker of any assignment for the benefit of creditors; (d) the failure of Maker generally to pay its debts as such debts become due; or
(e) taking of any corporate action by Maker in furtherance of any of the foregoing events described in Section 5.2(a) – Section
5.2(d).

 

5.3              
Involuntary Bankruptcy, Etc. The: (a)(i) entry of a decree or order for relief by a court having jurisdiction in
the premises in respect of Maker in an involuntary case under any applicable bankruptcy, insolvency or other similar law, (ii) appointment
of a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) of Maker or for any substantial part of its
property, or (iii) the ordering of the winding-up or liquidation of Maker’s affairs; and (b) continuance of any such decree, appointment,
or order unstayed and in effect for a period of 60 consecutive days.

 

6.            
Remedies.

 

6.1              
Upon the occurrence of an Event of Default specified in Section 5.1, Payee may, by Notice to Maker, declare this
Note to be due immediately and payable by Maker, whereupon the unpaid principal amount of this Note, and all other amounts payable hereunder,
shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly
waived, notwithstanding anything contained herein or in the documents evidencing the same to the contrary.

 

6.2              
Upon the occurrence of an Event of Default specified in Section 5.2 and Section 5.3, the unpaid principal
balance of this Note, and all other sums payable with regard to this Note, shall automatically and immediately become due and payable
by Maker, in all cases without any action on the part of Payee.

 

7.           
Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive: (a) presentment for payment, demand,
notice of dishonor, protest, and notice of protest with regard to the Note; (b) all errors, defects and imperfections in any proceedings
instituted by Payee under the terms of this Note; and (c) all benefits that might accrue to Maker by virtue of any present or future laws
(i) exempting any property, real or personal, or any part of the proceeds arising from any sale of any such real or personal property,
from attachment, levy or sale under execution, or (ii) providing for any stay of execution, exemption from civil process, or extension
of time for payment. Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof or any
writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.

 

    - 2 -

     

    

 

8.             
 Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default,
or enforcement of the payment of this Note, and agrees that Maker’s liability shall be unconditional, without regard to the liability
of any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted
or consented to by Payee. Maker consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by
Payee with respect to the payment or other provisions of this Note. Maker agrees that additional makers, endorsers, guarantors, or sureties
may become parties hereto without either any Notice to Maker or any bearing on Maker’s liability hereunder.

 

9.             
Notices. All notices, requests, consents, claims, demands, waivers, and other communications hereunder (each, a “Notice”)
shall be in writing and addressed to the parties at the addresses set forth on the first page of this Agreement (or to such other address
that may be designated by the receiving party from time to time in accordance with this Section 9). A Notice shall be deemed to
have been given (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally
recognized overnight courier (receipt requested); (c) on the date sent by facsimile or email (with confirmation of transmission) if sent
during normal business hours of the recipient, and on the next business day if sent after normal business hours of the recipient; or (d)
on the third day after the date mailed, by certified or registered mail (in each case, return receipt requested, postage pre-paid). .

 

10.          
Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF NEW YORK, WITHOUT REGARD TO CONFLICT
OF LAW PROVISIONS THEREOF.

 

11.          
Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such
jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof,
and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other
jurisdiction.

 

12.          
Trust Waiver. Notwithstanding anything herein to the contrary, Payee hereby waives any and all right, title, interest or claim
of any kind (each, a “Claim”) in or to any distribution of or from the trust account to be established (the “Trust
Account”), in which the proceeds of both the (a) IPO (including the deferred underwriters discounts and commissions) and (b)
sale of the warrants to be issued in a private placement to occur at the closing of the IPO are to be deposited, as described in greater
detail in the Registration Statement on Form S-1 and prospectus to be filed with the Securities and Exchange Commission in connection
with the IPO. Payee hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account
for any reason whatsoever.

 

13.          
Amendment; Waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent
of both Maker and Payee.

 

14.          
Assignment. No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by
operation of law or otherwise) without the prior written consent of the other party hereto. Any attempted assignment without the required
consent shall be void.

 

[Signature page follows]

 

    - 3 -

     

    

 

IN WITNESS WHEREOF,
Maker, intending to be legally bound hereby, has caused this Note to be duly executed by the undersigned as of the day and year first
above written.

 

	 	Gardiner
    Healthcare Acquisitions Corp.
	 	 
	 	 
	 	By: 	/s/ Marc F. Pelletier
	 	 	Name:   	Marc F. Pelletier
	 	 	Title: 	Chairman and Chief Executive Officer

 

[Signature Page to Second Amended & Restated
Promissory Note]Exhibit 10.11

 

[●], 2021

 

Gardiner Healthcare Acquisitions
Corp.

3107 Warrington Road

Shaker Heights, OH 44210

 

Ladies and Gentlemen:

 

Gardiner Healthcare Acquisitions
Corp. (the “Company”), a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition,
stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (a “Business
Combination”), intends to register its securities under the Securities Act of 1933, as amended (“Securities Act”), in
connection with its initial public offering (“IPO”), pursuant to a registration statement on Form S-1 (“Registration
Statement”).

 

The undersigned hereby commits
that it will purchase an aggregate of 3,337,500 warrants of the Company (“Private Warrants”) (or 3,632,813 Private Warrants
if the underwriters’ over-allotment option is exercised in full), at a price of $1.00 per Private Warrant for an aggregate purchase
price of $3,337,500 (or $3,632,813 if the underwriters’ over-allotment option is exercised in full) (the “Private Warrant
Purchase Price”).

 

At least twenty-four (24)
hours prior to the effective date of the Registration Statement, the undersigned will cause the Private Warrant Purchase Price to be delivered
to Reed Smith LLP as escrow agent, by wire transfer as set forth in the instructions attached as Exhibit A to hold in a non-interest bearing
account until the Company consummates the IPO.

 

The consummation of the purchase
and issuance of the Private Warrants shall occur simultaneously with the consummation of the IPO. Simultaneously with the consummation
of the IPO, Continental Stock Transfer & Trust Company (“Continental”) shall deposit $2,325,000 (or $2,620,314 if the
underwriters’ over-allotment option is exercised in full) of the Private Warrant Purchase Price, without interest or deduction,
into the trust account (“Trust Account”) established by the Company for the benefit of the Company’s public stockholders
and the remaining $1,012,500 shall be used by the Company for working capital, each as described in the Registration Statement.

 

Each of the Company and the
undersigned acknowledges and agrees that Reed Smith LLP is serving hereunder solely as a convenience to the parties to facilitate the
purchase of the Private Warrants.

 

    1

     

    

 

Additionally, the undersigned
agrees:

 

		●	not to propose, or vote in favor of, prior to or unrelated to an initial Business Combination, an
                                                                   amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the
                                                                   Company’s obligation to redeem 100% of the Company’s shares of common stock sold in the IPO if the Company does not
                                                                   complete an initial Business Combination within 12 months (or up to 18 months, if the time to complete a Business Combination is
                                                                   extended as described in the prospectus) from the closing of the IPO, unless the Company provides the holders of shares of common
                                                                   stock sold in the IPO with the opportunity to redeem their shares of common stock upon approval of any such amendment at a per-share
                                                                   price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds
                                                                   held in the Trust Account and not previously released to the Company to pay the Company’s franchise and income taxes, divided
                                                                   by the number of then outstanding shares of common stock sold in the IPO;

 

		●	the undersigned will not participate in any liquidation distribution with respect to the Private Warrants
(but will participate in liquidation distributions with respect to any units or common stock purchased by the undersigned in the IPO or
in the open market) if the Company fails to consummate a Business Combination;

 

		●	that the Private Warrants and underlying securities will not be transferable until 30 days after the consummation
of a Business Combination except (i) to the Company’s officers or directors, any affiliates or family members of any of the Company’s
officers or directors and any members or affiliates of the Company’s co-sponsors, (ii) by gift to a member of an individual’s
immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such
person or to a charitable organization, (iii) by virtue of the laws of descent and distribution upon death, (iv) pursuant to a qualified
domestic relations order, (v) by private sales or transfers made in connection with the consummation of an initial Business Combination
at prices no greater than the price at which the Private Warrants were originally purchased, (vi) in the event of the Company’s
liquidation prior to the completion of its initial Business Combination, (vii) by virtue of the laws of Delaware or Gardiner Healthcare
Holdings, LLC’s limited liability company agreement upon dissolution of Gardiner Healthcare Holdings, LLC, or (viii) to the Company
for cancellation in connection with the consummation of a Business Combination, in each case (except for clauses (vi) and (viii)) where
the transferee agrees to the terms of the transfer restrictions; and

 

		●	the Private Warrants will include any additional terms or restrictions as is customary in other similarly
structured blank check company offerings or as may be reasonably required by the underwriters in the IPO in order to consummate the IPO,
each of which will be set forth in the Registration Statement.

 

The undersigned acknowledges
and agrees that the purchaser of the Private Warrants will execute agreements in form and substance typical for transactions of this nature
necessary to effectuate the foregoing agreements and obligations prior to the consummation of the IPO as are reasonably acceptable to
the undersigned, including but not limited to an insider letter.

 

The undersigned also acknowledges
to be bound by the terms of the private warrants described in the warrant agreement between the Company and Continental that will be executed
in connection with the Company’s IPO.

 

    2

     

    

 

The undersigned hereby represents
and warrants that:

 

(a)              
it has been advised that the Private Warrants have not been registered under the Securities Act;

 

(b)              
it will be acquiring the Private Warrants for its account for investment purposes only;

 

(c)              
it has no present intention of selling or otherwise disposing of the Private Warrants in violation of the securities laws
of the United States;

 

(d)              
it is an “accredited investor” as defined by Rule 501 of Regulation D promulgated under the Securities Act;

 

(e)              
it has had both the opportunity to ask questions and receive answers from the officers and directors of the Company and
all persons acting on its behalf concerning the terms and conditions of the offer made hereunder;

 

(f)               
it is familiar with the proposed business, management, financial condition and affairs of the Company;

 

(g)              
it has full power, authority and legal capacity to execute and deliver this letter and any documents contemplated herein
or needed to consummate the transactions contemplated in this letter; and

 

(h)              
this letter constitutes its legal, valid and binding obligation, and is enforceable against it.

 

This letter agreement constitutes
the entire agreement between the undersigned and the Company with respect to the purchase of the Private Warrants, and supersedes all
prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, with respect to the same.

 

[SIGNATURE PAGE FOLLOWS]

 

    3

     

    

 

	 	Very truly yours,
	 	 
	 	GARDINER HEALTHCARE HOLDINGS, LLC
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

	Accepted and Agreed:	 
	 	 
	GARDINER HEALTHCARE ACQUISITIONS CORP.	 
	 	 
	By:	 	 
	 	Name: Marc F. Pelletier	 
	 	Title: Chief Executive Officer	 

 

[Signature Page to Private Placement Warrants Purchase Agreement]

 

     

     

    

 

Exhibit A

 

Wire Instructions

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]